Rokit Healthcare

주식회사 로킷헬스케어 · KOSDAQ · 376900 · Industry: Manufacture of other medical supplies and related other medicaments

Key metrics

Earnings

Revenue, Q3 2026₩6.1bn As of Sep 30, 2026 Source 1 ↗
Revenue QoQ-25.4% As of Sep 30, 2026 Source 1 ↗, Source 2 ↗
Revenue YoY-11.9% As of Sep 30, 2026 Source 1 ↗, Source 2 ↗
Operating income, Q3 2026-₩9.5bn As of Sep 30, 2026 Source 1 ↗
Operating income QoQ+29.6% As of Sep 30, 2026 Source 1 ↗, Source 2 ↗
Operating income YoYTurned to loss As of Sep 30, 2026 Source 1 ↗, Source 2 ↗

Share buybacks

Buyback decided, last 3 months₩0 As of Nov 19, 2026
Buyback decided, last 3 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗
Shares acquired, last 3 months₩0 As of Nov 19, 2026
Shares acquired, last 3 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗
Treasury shares cancelled, last 3 months₩0 As of Nov 19, 2026
Treasury shares cancelled (number), last 3 months0 shares As of Nov 19, 2026
Treasury shares cancelled, last 3 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗
Buyback decided, last 12 months₩0 As of Nov 19, 2026
Buyback decided, last 12 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗
Shares acquired, last 12 months₩0 As of Nov 19, 2026
Shares acquired, last 12 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗
Treasury shares cancelled, last 12 months₩0 As of Nov 19, 2026
Treasury shares cancelled (number), last 12 months0 shares As of Nov 19, 2026
Treasury shares cancelled, last 12 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗

Potential dilution

CB/BW/EB issued, last 12 months₩0 As of Nov 19, 2026
Rights offering new shares, last 12 months903,902 shares As of Mar 10, 2026 Source 1 ↗
Potential new shares, last 12 months1,291,283 shares As of Oct 19, 2026 Source 1 ↗, Source 2
Potential new shares, % of shares7.4% As of Oct 19, 2026 Source 1 ↗, Source 2, Source 3 ↗
Conversion price adjustments, last 12 months1 As of Oct 19, 2026 Source 1

Supply contracts

Supply contracts, last 12 months₩0 As of Nov 19, 2026
Supply contracts vs prior-year revenue0.0% As of Nov 19, 2026
Contracts without a KRW amount0 contracts without a KRW amount excluded As of Nov 19, 2026

Disclosure activity

DART filings, last 3 months5 As of Nov 19, 2026
DART filings, previous 3 months4 As of Nov 19, 2026

Insider transactions

Open-market buys, last 12 months (shares)0 shares As of Nov 19, 2026
Open-market buys, last 12 months (amount)₩0 As of Nov 19, 2026
Open-market sells, last 12 months (shares)0 shares As of Nov 19, 2026
Open-market sells, last 12 months (amount)₩0 As of Nov 19, 2026
Net open-market buying, last 12 months (shares)0 shares As of Nov 19, 2026
Insiders who bought, last 12 months0 As of Nov 19, 2026

Insider transactions (last 12 months)

Open-market buys: 0 shares (₩0). Open-market sells: 0 shares (₩0). Net open-market buying: 0 shares. Insiders who bought: 0.

Trade dateInsider (role)TypeSharesPriceAmount
Sep 11, 2026Lee Min-gu (Non-registered officer)Other (Other decrease)-28,500 shares——
May 15, 2026Gil Yun-gi (Non-registered officer)Other (Appraisal right exercise)+2,500 shares₩20,000₩50m
May 15, 2026Kim Dae-yeong (Non-registered officer)Other (Other decrease)0 shares——
May 15, 2026Kim Dae-yeong (Non-registered officer)Other (Other decrease)0 shares——
May 15, 2026Yoo Seok-hwan (Registered director, Controlling shareholder)Other (Other decrease)0 shares——
May 15, 2026Lee Min-gu (Non-registered officer)Other-2,500 shares——
May 15, 2026Lee Min-gu (Non-registered officer)Other (Appraisal right exercise)+2,500 shares₩20,000₩50m
May 15, 2026Lee Sang-min (Registered director)Other (Other decrease)0 shares——
May 15, 2026Lee Sang-min (Registered director)Other (Other decrease)0 shares——
May 15, 2026Lee Yeong-il (Non-registered officer)Other (Other decrease)0 shares——
Apr 21, 2026Gil Yun-gi (Non-registered officer)Other-2,500 shares₩20,000₩50m
Mar 31, 2026Jung Cheol-hwa (Registered director)Other (New appointment)+6,000 shares——
Mar 31, 2026Lee Min-gu (Non-registered officer)Other (Stock option exercise)+10,000 shares——Reported late
Mar 31, 2026Lee Yeong-il (Non-registered officer)Other (Stock option exercise)+10,000 shares——Reported late

Annual financials

YearRevenueOperating income
2025₩26.2bn₩453m
2024₩13.1bn-₩5.6bn
2023₩12.4bn-₩7.4bn

Filing timeline